7
Views
0
CrossRef citations to date
0
Altmetric
ONCOLOGY

Incidence trends of cervical adenocarcinoma in Israeli Jewish women. A population-based study

, , &
Pages 280-285 | Received 04 Oct 2008, Published online: 21 Jul 2009
 

Abstract

Objective. To assess the trend over time of the relative frequency and incidence of adenocarcinoma (AC) in Israeli Jewish women. Design. Register study. Setting. Israel National Cancer Registry. Population. All cases of histologically proven invasive cervical cancer diagnosed during two time periods: 1961–1971 and 2002–2004. Methods. Calculation of frequencies and incidence rates and comparison by the χ2 test and by the Poisson regression model, respectively. Main outcome measures. Frequency and incidence of AC. Results. There were a total of 532 women with a diagnosis of cervical cancer during the first and 434 women during the second period (incidence 4.2 and 4.7/100,000, respectively). The total incidence rates and frequency rates of AC during the two periods were statistically not different. The frequency rate of AC during the second period was significantly higher in the 20–29 and the 40–49 age groups and in the North African born than in the other ethnic groups. Conclusions. Our study indicates that except in certain age and ethnic groups, the frequency and incidence of AC has not significantly altered in Israel over the time periods studied.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.